Rashida Monique Johnson

Array ( [id] => 3884833 [patent_doc_number] => 05714334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Gene and method for production of an IgA binding protein' [patent_app_type] => 1 [patent_app_number] => 8/782009 [patent_app_country] => US [patent_app_date] => 1997-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7472 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714334.pdf [firstpage_image] =>[orig_patent_app_number] => 782009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770062 [patent_doc_number] => 05849705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Method for the treatment of Schwann cells in vivo' [patent_app_type] => 1 [patent_app_number] => 8/761762 [patent_app_country] => US [patent_app_date] => 1996-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 5847 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849705.pdf [firstpage_image] =>[orig_patent_app_number] => 761762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933543 [patent_doc_number] => 05929032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Method for treating Schwann and colon cells in vitro' [patent_app_type] => 1 [patent_app_number] => 8/761038 [patent_app_country] => US [patent_app_date] => 1996-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6132 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929032.pdf [firstpage_image] =>[orig_patent_app_number] => 761038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785349 [patent_doc_number] => 05736400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers' [patent_app_type] => 1 [patent_app_number] => 8/759264 [patent_app_country] => US [patent_app_date] => 1996-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10832 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736400.pdf [firstpage_image] =>[orig_patent_app_number] => 759264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4033320 [patent_doc_number] => 05856138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Human parathyroid hormone muteins and production thereof' [patent_app_type] => 1 [patent_app_number] => 8/733446 [patent_app_country] => US [patent_app_date] => 1996-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 33 [patent_no_of_words] => 19723 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856138.pdf [firstpage_image] =>[orig_patent_app_number] => 733446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848266 [patent_doc_number] => 05719127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Modified complement system regulators' [patent_app_type] => 1 [patent_app_number] => 8/688675 [patent_app_country] => US [patent_app_date] => 1996-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10150 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 623 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719127.pdf [firstpage_image] =>[orig_patent_app_number] => 688675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738600 [patent_doc_number] => 05753502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Neuron-specific ICAM-4 promoter' [patent_app_type] => 1 [patent_app_number] => 8/656984 [patent_app_country] => US [patent_app_date] => 1996-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18457 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753502.pdf [firstpage_image] =>[orig_patent_app_number] => 656984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862083 [patent_doc_number] => 05837242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Multivalent and multispecific binding proteins, their manufacture and use' [patent_app_type] => 1 [patent_app_number] => 8/448418 [patent_app_country] => US [patent_app_date] => 1996-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 52 [patent_no_of_words] => 49061 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837242.pdf [firstpage_image] =>[orig_patent_app_number] => 448418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693681 [patent_doc_number] => 05661005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => '.beta.3 integrin subunit specific polypeptides, cDNAS which encode these polypeptides and methods of producing these polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/597583 [patent_app_country] => US [patent_app_date] => 1996-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3765 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661005.pdf [firstpage_image] =>[orig_patent_app_number] => 597583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044887 [patent_doc_number] => 05869270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Single chain MHC complexes and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/596387 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 82 [patent_no_of_words] => 46590 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869270.pdf [firstpage_image] =>[orig_patent_app_number] => 596387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850516 [patent_doc_number] => 05767077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Human Fc-.gamma. receptor III' [patent_app_type] => 1 [patent_app_number] => 8/481939 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6128 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767077.pdf [firstpage_image] =>[orig_patent_app_number] => 481939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810916 [patent_doc_number] => 05811517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'ICAM-related protein variants' [patent_app_type] => 1 [patent_app_number] => 8/483389 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 55266 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811517.pdf [firstpage_image] =>[orig_patent_app_number] => 483389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3792749 [patent_doc_number] => 05780426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Fivemer cyclic peptide inhibitors of diseases involving .alpha..sub.v .beta..sub.3' [patent_app_type] => 1 [patent_app_number] => 8/482107 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17536 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780426.pdf [firstpage_image] =>[orig_patent_app_number] => 482107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766385 [patent_doc_number] => 05773218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method to identify compounds which modulate ICAM-related protein interactions' [patent_app_type] => 1 [patent_app_number] => 8/482882 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 54396 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773218.pdf [firstpage_image] =>[orig_patent_app_number] => 482882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646033 [patent_doc_number] => 05629162 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Method of identifying agents which modulate ICAM-3 binding to LFA-1' [patent_app_type] => 1 [patent_app_number] => 8/473981 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 49 [patent_no_of_words] => 22419 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629162.pdf [firstpage_image] =>[orig_patent_app_number] => 473981 [rel_patent_id] =>[rel_patent_doc_number] =>)